SMTL ID : 8ba4.1 (1 other biounit)

Crystal structure of JAK2 JH2-V617F in complex with Bemcentinib

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.10 Å

Oligo State

monomer

Ligands

1 x Q8U: 1-(3,4-diazatricyclo[9.4.0.0^{2,7}]pentadeca-1(11),2(7),3,5,12,14-hexaen-5-yl)-~{N}3-[(7~{S})-7-pyrrolidin-1-yl-6,7,8,9-tetrahydro-5~{H}-benzo[7]annulen-3-yl]-1,2,4-triazole-3,5-diamine(Non-covalent)

Q8U.1: 27 residues within 4Å: Chain A: L.16, Q.18, G.19, T.20, T.22, I.24, L.44, K.46, V.75, Q.91, E.92, F.93, V.94, K.95, F.96, G.97, S.98, T.101, Y.102, N.138, K.142, N.143, L.145, S.163, D.164, P.165, G.166 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:L.16, A:L.16, A:I.24, A:F.93, A:L.145 Hydrogen bonds: A:E.92, A:V.94, A:V.94 pi-Cation interactions: A:K.46

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Virtanen, A.T. et al., Identification of Novel Small Molecule Ligands for JAK2 Pseudokinase Domain. Pharmaceuticals (2023)

Release Date

2023-02-01

Peptides

Tyrosine-protein kinase JAK2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase JAK2

Related Entries With Identical Sequence